ArticleBMC cancer2022

Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial.

Pamela M J McLaughlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.